Simon Bury has been named business development director of the Discovery division of Selcia Ltd. Mr. Bury will lead expansion plans in the company’s drug discovery offering.

Mr. Bury has more than 30 years of commercial experience within the life sciences industry, with a strong mix of technical, strategic and business development expertise. He was most recently chief commercial officer for Cyprotex Discovery Ltd., where he was responsible for the company’s global sales and marketing activities. Prior to Cyprotex, Mr. Bury held senior business development roles at Shanghai ChemPartner, Scottish Biomedical, Pharmacopeia, Hewlett-Packard and Zymark.

Simon Saxby, chief executive officer of Selcia, said, “We are delighted to welcome Simon Bury to Selcia Discovery’s rapidly expanding team. We look forward to Simon helping us develop our integrated drug Discovery division, and accelerate our growth into this strategic area, complementing our other world leading contract research services.”

On joining Selcia, Mr. Bury commented, “Selcia Discovery has established a fabulous reputation for delivering high quality integrated drug discovery services to the global pharmaceutical and biotechnology industry. I am very much looking forward to using my experience to further advance this business.”